Pharvaris CEO Berndt Modig reports share holdings
Pharvaris N.V. director and Chief Executive Officer Berndt Modig filed an initial ownership report showing his equity position in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pharvaris N.V. director and Chief Executive Officer Berndt Modig filed an initial ownership report showing his equity position in the company. He directly holds 165,417 shares of common stock, plus additional restricted stock units that vest over time. He also has indirect ownership of 950,000 common shares through Schoodic Management B.V., an entity he controls. In addition, he holds multiple stock option awards on common shares with exercise prices ranging from $8.05 to $28.00 and expiration dates between 2031 and 2036, providing long-dated upside exposure tied to the company’s share price.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (8)
- F1. Includes restricted stock units previously granted under the Company's equity plan that remain outstanding as of March 18, 2026. The awards settle in shares of common stock and are reported in Table I as non-derivative securities. Vesting occurs as follows: -70,000 RSUs from an award granted March 3, 2026 of which 25% will vest March 3, 2027 with the remainder vesting monthly thereafter; -45,000 RSUs from an award granted March 12, 2025 of which 25% vested March 12, 2026 with the remainder vesting monthly thereafter; -26,042 RSUs from an award granted April 11, 2024 of which 25% vested April 11, 2025 with the remainder vesting monthly thereafter.
- F2. Schoodic Management B.V., an entity controlled by Mr. Modig
- F3. 25% of the option will vest on March 3, 2027 with the remaining shares vesting in 1/48 monthly installments thereafter.
- F4. 25% of the option vested on March 12, 2026 with the remaining shares vesting in 1/48 monthly installments thereafter.
- F5. 25% of the option vested on April 11, 2025 with the remaining shares vesting in 1/48 monthly installments thereafter.
- F6. 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
- F7. 25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.
- F8. 25% of the option vested on February 2, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Berndt Modig’s Form 3 filing for Pharvaris (PHVS) show?
What stock options does the Pharvaris (PHVS) CEO report on his Form 3?
Does the Pharvaris (PHVS) Form 3 show any recent insider buying or selling?
How are Schoodic Management B.V. holdings treated in the Pharvaris (PHVS) Form 3?
What restricted stock units (RSUs) are outstanding for the Pharvaris (PHVS) CEO?
AI-generated analysis. How Rhea-AI works. Not financial advice.
